KALY Patented Cannabis Extract COPD Treatment Research Validates Pharmaceutical Potential
25 3월 2019 - 11:28PM
InvestorsHub NewsWire
New
York, NY -- March 25, 2019 -- InvestorsHub NewsWire --
via NextBigtTcker.com
Kali-Extracts, Inc. (USOTC:
KALY) last Friday, March 22nd, published the
research results from the recent trial of its pilot treatment for Chronic Obstructive Pulmonary
Disease (COPD) in primates using an extract derived from
KALY's patented cannabis extraction process. The independent
research publication reported that the KALY compound improved
respiration in infected primates further validating previous in
vitro studies of KALY’s cannabis compound. The research
publication recommended next stage trials. The research
publication elevates KALY from just having a patented extraction
process to actually having the potential of being able to produce a
cannabis extract pharmaceutical product.
KALY Potential PPS Run From $0.01 to
$0.10
KALY
has the potential to run from its $0.01 PPS level to $0.10 in the
near term. Shortly after the 2018 Q4 acquisition of the patented
cannabis extraction process, the company PPS shot from sub-penny
land to almost $0.04 on volume that put it in the top 20 most
actively traded stocks on the OTC Market. The PPS retraced back to
$0.01 and has been holding that price with a healthy trading
volume. With the research publication now validating KALY as
a serious pharmaceutical contender, the PPS is positioned to shoot
past the recent $0.04 highs to a level putting it on par with some
of the other penny cannabis stock contenders such as PotNetworks
Holdings, Inc. (USOTC:
POTN) and Medical Marijuana, Inc. (USOTC:
MJNA). A $0.10 PPS is a reasonable milestone following
the company filing its upcoming annual reported expected to include
the company posting its first revenue derived from its cannabis
extraction process.
KALY is
providing CBD extracts for over $1 million worth of CBD infused
water produced by Puration, Inc. (USOTC:
PURA), and KALY has also introduced its own CBD infused
gum. When the annual report is published in April, the first
sales will be officially on the books and likely catapult the KALY
PPS up to the $0.10 range were it justifiably should be.
Between now and the filing of the annual report, the KALY PPS
stands to return to its previous $0.04 high on anticipated news
regarding its cannabis pharmaceutical developments and wellness
product sales.
Following the acquisition of the patented
cannabis extraction process late last year and the corresponding
jump in price and trading volume, the OTC Markets flagged the
company in response to the jump in activity. The company has
responded by updating all its OTC Markets required reports.
Management is likely to mitigate the OTC Market’s concerns sooner
or later and see the flag removed which will likely be yet another
impetus fueling a KALY PPS run. It could be a good time to
accumulate KALY now under $0.04 before the positing of the
company’s annual report or the removal of the OTC Markets
flag.
Management engaged Goldman Small Cap Research to
conduct analyst coverage of the company and file an initial analyst
report: KALY Research
Report
Disclaimer/Safe Harbor:
This
news release contains forward-looking statements within the meaning
of the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur.
Source: www.nextbigticker.com
Medical Marijuana (PK) (USOTC:MJNA)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Medical Marijuana (PK) (USOTC:MJNA)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
Medical Marijuana Inc (PK) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Medical Marijuana, Inc. (PC) News Articles